If a patient wants to add a third peptide such as CJC/Ipamorelin or GHK-Cu to the Wolverine Stack, that moves the protocol to a 2-Peptide Stack at $795 per cycle
Available from: Mallick H, Franzosa EA, Mclver LJ, Banerjee S, Sirota-Madi A, Kostic AD, et al
Currently, the BPC-157 / TB-500 blend is being investigated for its potential applications in soft tissue regeneration, tendon and ligament repair models, inflammation modulation, and cellular migration studies
[16] [17] [18] It was also established that GHK-Cu stimulates both the synthesis of metalloproteinases, the enzymes which break down dermal proteins, and their inhibitors (anti-proteases)
So the better question is not: Which form is stronger
(More on this below in the Parkinsons section.) There are a couple of differences in the tissue distribution of the MAOs